United Kingdom Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-10-26
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-united-kingdom
United Kingdom Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-10-26: 10Y at 5.80%, fitted curve 3M–30Y (4.74%–6.20%), 67 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 3M | 4.74% | — |
| 6M | 4.78% | 4.92% |
| 9M | 4.81% | 4.98% |
| 18M | 4.91% | 5.07% |
| 2Y | 4.98% | 5.26% |
| 3Y | 5.11% | 5.47% |
| 4Y | 5.24% | 5.73% |
| 5Y | 5.35% | 5.98% |
| 6Y | 5.46% | 6.20% |
| 7Y | 5.56% | 6.38% |
| 8Y | 5.65% | 6.54% |
| 9Y | 5.73% | 6.67% |
| 10Y | 5.80% | 6.77% |
| 15Y | 6.03% | 6.91% |
| 20Y | 6.13% | 6.87% |
| 25Y | 6.18% | 6.71% |
| 30Y | 6.20% | 6.56% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.98% and the 10-year 5.80%, a 10Y−2Y spread of +82 bp — positively sloped — as of 2026-10-26. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-10-26 | 1m ago2026-09-25 | 2m ago2026-08-27 | 3m ago2026-07-28 | 4m ago2026-06-29 | 5m ago2026-05-29 | 6m ago2026-04-29 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.98% | 5.16% | 4.57% | 4.66% | 4.45% | 4.38% | 4.23% |
| 10Y | 5.80% | 5.95% | 5.40% | 5.37% | 5.13% | 5.08% | 5.00% |
| 10Y − 2Y | +82 bp | +79 bp | +83 bp | +71 bp | +67 bp | +70 bp | +77 bp |
Bonds in this curve
A selection of 30 of the 72 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Astrazeneca | 4.52% | 2027-02-26 | 4.80% | US04636NAK90 |
| GSK Capital INC | 4.39% | 2027-03-12 | 4.32% | US377373AM70 |
| CSL Finance | 5.11% | 2027-04-27 | 3.85% | USG2584CAA48 |
| Astrazeneca | 4.57% | 2027-06-12 | 3.12% | US046353AN82 |
| Royalty Pharma | 4.88% | 2027-09-02 | 1.75% | US78081BAJ26 |
| Astrazeneca | 4.79% | 2028-03-03 | 4.88% | US04636NAF06 |
| GSK Capital INC | 4.92% | 2028-05-15 | 3.88% | US377372AN70 |
| Astrazeneca | 4.86% | 2029-01-17 | 4.00% | US046353AT52 |
| CSL Finance | 5.32% | 2029-04-27 | 4.05% | USG2584CAB21 |
| GSK Capital INC | 5.02% | 2029-06-01 | 3.38% | US377373AH85 |
| Haleon | 5.19% | 2029-08-21 | 4.62% | US40555XAA00 |
| Astrazeneca | 5.21% | 2030-08-06 | 1.38% | US046353AW81 |
| Royalty Pharma | 5.47% | 2030-09-02 | 2.20% | US78081BAK98 |
| Astrazeneca | 5.22% | 2031-05-28 | 2.25% | US04636NAB91 |
| CSL Finance | 5.55% | 2032-04-27 | 4.25% | USG2584CAC04 |
| Astrazeneca | 5.29% | 2033-03-03 | 4.88% | US04636NAH61 |
| Astrazeneca | 5.37% | 2033-03-02 | 4.30% | US04636NAR44 |
| GSK Capital INC | 5.43% | 2033-09-15 | 5.25% | US377372AU14 |
| Astrazeneca | 5.44% | 2034-02-26 | 5.00% | US04636NAN30 |
| Royalty Pharma | 5.85% | 2034-09-02 | 5.40% | US78081BAR42 |
| GSK Capital INC | 5.59% | 2035-04-15 | 4.88% | US377372AQ02 |
| Royalty Pharma | 5.86% | 2035-09-25 | 5.20% | US78081BAU70 |
| Astrazeneca | 5.54% | 2036-03-02 | 4.60% | US04636NAS27 |
| Haleon | 5.81% | 2036-08-21 | 5.38% | US40555XAC65 |
| Smith & Nephew | 6.02% | 2036-09-11 | 5.75% | US83192PAE88 |
| Royalty Pharma | 6.10% | 2040-09-02 | 3.30% | US78081BAL71 |
| Astrazeneca | 5.89% | 2042-09-18 | 4.00% | US046353AG32 |
| Astrazeneca | 6.01% | 2045-11-16 | 4.38% | US046353AM00 |
| Royalty Pharma | 6.34% | 2050-09-02 | 3.55% | US78081BAM54 |
| Royalty Pharma | 6.36% | 2055-09-25 | 5.95% | US78081BAV53 |